-
Nvidia, Affirm Holdings, Carnival Corp, Alnylam Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Monday, June 24, 2024 - 10:18pm | 626Read More...On Monday, major U.S. indices showed mixed performance. The Dow Jones Industrial Average closed up by nearly 0.7% at 39,411.21, while the S&P 500 fell 0.3% to 5,447.87. The Nasdaq decreased by almost 1.1% to 17,496.82. These are the top stocks that gained the attention of retail traders and...
-
Benzinga's Bulls & Bears: Looking Back, Looking Forward
Sunday, December 24, 2017 - 10:05am | 742Read More...Benzinga has featured a look at many investor favorite stocks over the past week. Some recent posts took a look back at the past year. Many others were forward focused, including forecasts for the top tech darling. The end of the year is nearly upon us. As it does every week, Benzinga...
-
Short Sellers Dump Vertex, Load Up On Baxalta
Thursday, April 28, 2016 - 8:34am | 588Read More...Short interest in many leading biotech stocks declined in the most recent period. Bucking that trend is a biotech company that soon will be acquired by an overseas peer. Short sellers retreated most sharply from a biotech that some analysts now see as a value stock. Between the March 31 and April...
-
Microsoft, Bank Of New York And Others Insiders Have Been Buying
Monday, February 2, 2015 - 9:57am | 782Read More...Secondary offerings by small biotech companies have brought out the insider buyers recently, as did the sell-off following Microsoft's disappointing quarterly report. Insiders may sell shares for any number of reasons, but conventional wisdom says that they really only buy shares of a company for...
-
Shares Of Alnylam Pharmaceuticals Lower Following Equity Offering
Wednesday, January 21, 2015 - 11:03am | 109Read More...Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) tumbled 4 percent Wednesday morning as the company priced 4.73 million shares of common stock at $95 per share after announcing on Tuesday it plans to initiate a public offering of common stock. All of the shares being offering will be sold by...
-
5 Companies That Could Develop An Enterovirus Treatment
Monday, October 13, 2014 - 8:07am | 926Read More...When it comes to the search for Ebola treatments, names like BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), Chimerix Inc (NASDAQ: CMRX), Sarepta Therapeutics Inc (NASDAQ: SRPT) and Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) have cropped up frequently. Could these or other biotech companies...
-
Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases
Monday, January 13, 2014 - 5:52pm | 2370Read More...Investors and traders were in clear selling mode today ahead of a very busy week of earnings. The Dow suffered a triple digit point loss while the S&P 500 and Nasdaq suffered losses of more than one percent. There were no key economic data releases today. Related: Earnings Expectations For...
-
Piper Jaffray Maintains Neutral on Alnylam Pharmaceuticals
Monday, June 6, 2011 - 7:40am | 142Read More...Piper Jaffray is out with its report today on Alnylam Pharmaceuticals (NASDAQ: ALNY), maintaining Neutral. In a note to clients, Piper Jaffray writes, "Alnylam presented Phase I data on ALN-VSP02 in liver cancer at the American Society of Clinical Oncology meeting in Chicago on Saturday. ALN-VSP02...
-
Piper Jaffray Maintains Neutral Rating, $10 PT On ALNY
Tuesday, April 19, 2011 - 1:55pm | 155Read More...Piper Jaffray is maintaining its Neutral rating and $10 PT on shares of Alnylam Pharmaceuticals (NASDAQ: ALNY). “This morning, Alnylam announced a new siRNA delivery collaboration with Precision NanoSystems,” Piper Jaffray writes. “Alnylam has worked with several delivery partners including...
